SEER Limited-Use cancer incidence data with associated population data. Geographic areas available are county and SEER registry. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute collects and distributes high quality, comprehensive cancer data from a number of population-based cancer registries. Data include patient demographics, primary tumor site, morphology, stage at diagnosis, first course of treatment, and follow-up for vital status. The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and survival rates within each stage.

The purpose of the National Oncology Register (hereinafter referred to as NOR) is the registration of oncological diseases and periodic monitoring of their further development, i.e. data collection, verification, storage, protection and processing. NOR provides summary data for statistical overviews at both national and international levels, as well as for epidemiological studies and health research. NOR is a nationwide population register that follows on from the monitoring of neoplasms in the population of the Czech Republic introduced in the 1950s, and as a population register of records of individual neoplasms, the ÚZIS of the Czech Republic has been operating since 1976.

NOR data are also used to support early diagnosis and treatment of neoplasms and pre-cancerous conditions, to monitor trends in their occurrence, causative factors and social consequences. At the population level, the results of the treatment of neoplasms are also evaluated in the form of a survival analysis.

Characteristics for young breast cancer patients, NCDB 2007–2013.

The Welsh Cancer Intelligence & Surveillance Unit (WCISU) is the National Cancer Registry for Wales and its primary role is to record, store and report on all incidence of cancer for the resident population of Wales wherever they are treated. Cancer registration in Wales began almost five decades ago and today’s electronic database which holds records going back to 1972 contains in the region of 686,000 records.

WCISU collects data about occurrences of cancer in Welsh residents via direct or indirect submissions from Welsh Hospitals.

Staging of malignant melanoma (ICD 10 code C43), breast (C50), colorectal (C18-C20) and cervix (C53) started in 2001 since this was when we started receiving pathological information. Staging for all other cancers started in 2010.

Treatment information started in 1995.

National Cancer Institute’s Cancer registry is a nationwide and population-based cancer registry, which covers all territory of Lithuania and it collects information about all new cancer cases (ICD-10-AM codes: C00-C96, D00-D09, D32-D33, D39.1, D42-D43, D45-D47) of all cancer patients.

The main task of the Cancer Registry is to guarantee as complete and reliable registration of incident cancer cases as possible.

In 1984 the Lithuanian Cancer Registry was established at the National Cancer Institute by the Order of the Minister of Health. The population-based Cancer Registry was set up in 1990.

As of my last update in January 2022, I don't have access to specific real-time datasets, including a specific "US cancer analysis dataset." However, there are several well-known sources where you might find such datasets:

1. Surveillance, Epidemiology, and End Results (SEER) Program: SEER is a comprehensive source of cancer statistics in the United States, operated by the National Cancer Institute (NCI). They provide a wide range of cancer-related data including incidence, mortality, survival, and population-based data on cancer cases.

2. National Program of Cancer Registries (NPCR): This program, also managed by the Centers for Disease Control and Prevention (CDC), collects cancer incidence data at the state level.

3. CDC WONDER: The CDC's Wide-ranging Online Data for Epidemiologic Research (WONDER) platform provides access to a wide array of public health-related datasets, including cancer statistics.

4. National Cancer Database (NCDB): This database, jointly sponsored by the American College of Surgeons and the American Cancer Society, contains hospital registry data from over 1,500 Commission on Cancer (CoC)-accredited facilities.

5. National Health Interview Survey (NHIS): While not specific to cancer, the NHIS collects data on health and health-related behaviors, which may include information on cancer screenings, risk factors, and prevalence.

6. Behavioral Risk Factor Surveillance System (BRFSS): Similar to NHIS, BRFSS collects state-based, cross-sectional data about U.S. residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services, which may include cancer-related data.

7. National Health and Nutrition Examination Survey (NHANES): NHANES collects data on the health and nutritional status of a nationally representative sample of the U.S. population through interviews, physical examinations, and laboratory tests, which may include cancer-related information.

When accessing these datasets, it's essential to review their documentation thoroughly to understand the variables available, the methodology of data collection, any limitations or biases, and the terms of use. Additionally, many of these datasets require approval or registration before access is granted.

Imaging Data Commons (IDC) is a repository within the Cancer Research Data Commons (CRDC) that manages imaging data and enables its integration with the other components of CRDC. IDC hosts a growing number of imaging collections that are contributed by either funded US National Cancer Institute (NCI) data collection activities, or by the individual researchers.Image data hosted by IDC is stored in DICOM format.

Users can access data about cancer statistics in the United States including but not limited to searches by type of cancer and race, sex, ethnicity, age at diagnosis, and age at death. Background Surveillance Epidemiology and End Results (SEER) database’s mission is to provide information on cancer statistics to help reduce the burden of disease in the U.S. population. The SEER database is a project to the National Cancer Institute. The SEER database collects information on incidence, prevalence, and survival from specific geographic areas representing 28 percent of the United States population. User functionality Users can access a variety of reso urces. Cancer Stat Fact Sheets allow users to look at summaries of statistics by major cancer type. Cancer Statistic Reviews are available from 1975-2008 in table format. Users are also able to build their own tables and graphs using Fast Stats. The Cancer Query system provides more flexibility and a larger set of cancer statistics than F ast Stats but requires more input from the user. State Cancer Profiles include dynamic maps and graphs enabling the investigation of cancer trends at the county, state, and national levels. SEER research data files and SEER*Stat software are available to download through your Internet connection (SEER*Stat’s client-server mode) or via discs shipped directly to you. A signed data agreement form is required to access the SEER data Data Notes Data is available in different formats depending on which type of data is accessed. Some data is available in table, PDF, and html formats. Detailed information about the data is available under “Data Documentation and Variable Recodes”.

The Cancer Registries (RT) are structures responsible for the collection and registration of all tumors occurring in a given territory. The primary role of a Cancer Registry is to establish and manage over time an archive of all new cancer cases diagnosed and to ensure that the data is recorded rigorously and continuously and systematically.
Most of the Italian registers are population registers, that is, they collect data relating to cancer diseases of all the residents of a given territory (it can be a single city or an entire region, a province or the territory of an ASL).
Alongside the general population registers, there are specialized registers, which collect information on a single type of tumor or on specific age groups or on occupational cancers.

Characteristics of the study population, by age group.

The United States Cancer Statistics (USCS) online databases in WONDER provide cancer incidence and mortality data for the United States for the years since 1999, by year, state and metropolitan areas (MSA), age group, race, ethnicity, sex, childhood cancer classifications and cancer site. Report case counts, deaths, crude and age-adjusted incidence and death rates, and 95% confidence intervals for rates. The USCS data are the official federal statistics on cancer incidence from registries having high-quality data and cancer mortality statistics for 50 states and the District of Columbia. USCS are produced by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI), in collaboration with the North American Association of Central Cancer Registries (NAACCR). Mortality data are provided by the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Vital Statistics System (NVSS).

The NCI DIS 3D database is a collection of 3D structures for over 400,000 drugs. The database is an extension of the NCI Drug Information System. The structural information stored in the DIS is only the connection table for each drug. The connection table is just a list of which atoms are connected and how they are connected. It is essentially a searcheable database of three-dimensional structures has been developed from the chemistry database of the NCI Drug Information System (DIS), a file of about 450,000 primarily organic compounds which have been tested by NCI for anticancer activity. The DIS database is very similar in size and content to the proprietary databases used in the pharmaceutical industry; its development began in the 1950s; and this history led to a number of problems in the generation of 3D structures. This information can be searched to find drugs that share similar patterns of connections, which can correlate with similar biological activity. But the cellular targets for drug action, as well as the drugs themselves, are 3 dimensional objects and advances in computer hardware and software have reached the point where they can be represented as such. In many cases the important points of interaction between a drug and its target can be represented by a 3D arrangement of a small number of atoms. Such a group of atoms is called a pharmacophore. The pharmacophore can be used to search 3D databases and drugs that match the pharmacophore could have similar biological activity, but have very different patterns of atomic connections. Having a diverse set of lead compounds increases the chances of finding an active compound with acceptable properties for clinical development. Sponsor: The ICBG are supported by the Cooperative Agreement mechanism, with funds from nine components of the NIH, the National Science Foundation, and the Foreign Agricultural Service of the USDA.

Rapid Cancer Registration Data (RCRD) provides a quick, indicative source of cancer data. It is provided to support the planning and provision of cancer services. The data is based on a rapid processing of cancer registration data sources, in particular on Cancer Outcomes and Services Dataset (COSD) information. In comparison, National Cancer Registration Data (NCRD) relies on additional data sources, enhanced follow-up with trusts and expert processing by cancer registration officers. The Rapid Cancer Registration Data (RCRD) may be useful for service improvement projects including healthcare planning and prioritisation. However, it is poorly suited for epidemiological research due to limitations in the data quality and completeness.

This is the result data of the cooperative staging survey (target cancer types: stomach cancer, colon cancer, rectal cancer, breast cancer) provided by the Central Cancer Registry of the National Cancer Center. This data is a service that provides cooperative staging survey information for stomach cancer patients at the National Cancer Center. It includes patient-specific diagnosis information related to the stage classification of stomach cancer (e.g. TNM stage), and is used for evaluating cancer progression and establishing treatment plans. It is useful for analyzing patient distribution by cooperative stage, predicting prognosis, evaluating treatment effectiveness, and clinical research. The data can also be applied for and used through the Central Cancer Registry data provision homepage. *Data provision homepage: https://kccrsurvey.cancer.go.kr/index.do

Difference-in-differences analysis for receipt and time to treatment among young breast cancer patients, NCDB 2007–2013.

This data was collected by the National Cancer Institute in 2021. This dataset provides detailed information on lung cancer patients, covering demographic attributes, medical history, treatment specifics, and survival outcomes.

Abstract

The Greater Bay Area Cancer Registry (GBACR), in compliance with California state law, gathers information about all cancers diagnosed or treated in a nine-county area (Alameda, Contra Costa, Marin, Monterey, San Benito, San Francisco, San Mateo, Santa...

Documentation

PHS does NOT host these data. This listing is information only.

The Greater Bay Area Cancer Registry (GBACR), in compliance with California state law, gathers information about all cancers diagnosed or treated in a nine-county area (Alameda, Contra Costa, Marin, Monterey, San Benito, San Francisco, San Mateo, Santa Clara and Santa Cruz). This information is obtained from medical records provided by hospitals, doctors\342\200\231 offices, and other related facilities.

The information, stored under secure conditions with strict regulations that protect confidentiality, helps the GBACR understand cancer occurrence and survival in the Greater Bay Area. For each patient, the information includes basic demographic facts like age, gender, and race/ethnicity, as well as cancer type, extent of disease, treatment and survival. Combined over the diverse Bay Area population, this information gives the GBACR and all users an opportunity to learn how such characteristics may be related to cancer causes, mortality, care and prevention.

In addition to its local use, information collected by the GBACR becomes part of state and federal population-based registries whose mission is to monitor cancer occurrence at the state and national levels, respectively. Data from the GBACR have contributed to the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) program since 1973. The nine counties are also part of the statewide California Cancer Registry (CCR), which conducts essential monitoring of cancer occurrence and survival in California.

GBACR data are of the highest quality, as recognized by national and international registry standard-setting organizations, including SEER, the National Program for Cancer Registries, and the North American Association for Central Cancer Registries (NAACCR).

The CPIC has also started collecting data on environmenal factors. These data are available in the The California Neighborhoods Data System. This a new resource for examining the impact of neighborhood characteristics on cancer incidence and outcomes in populations includes a compilation of existing geospatial and other secondary data for characterizing contextual factors

A summary and description of social and built environment data and measures in the California Neighborhoods Data System (2010) can be found here: Social and Built Environment Data and Measures

More information about this new data source can be found here: The California Neighborhoods Data System

Patient characteristics All reported cancer cases in the state of California.

Data overview Data categories Socioeconomic status Racial/ethnic composition Immigration/acculturation characteristics Racial/ethnic residential segregation Population density Urbanicity (Rural/Urban) Housing Businesses Commuting Street connectivity Parks Farmers Markets Traffic density Crime Tapestry Segmentation

Notes To apply for these data, you can see instructions here: https://www.ccrcal.org/retrieve-data/data-for-researchers/how-to-request-ccr-data/

The State Cancer Profiles (SCP) web site provides statistics to help guide and prioritize cancer control activities at the state and local levels. SCP is a collaborative effort using local and national level cancer data from the Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR) and National Cancer Institute's Surveillance, Epidemiology and End Results Registries (SEER). SCP address select types of cancer and select behavioral risk factors for which there are evidence-based control interventions. The site provides incidence, mortality and prevalence comparison tables as well as interactive graphs and maps and support data. The graphs and maps provide visual support for deciding where to focus cancer control efforts.

The aims of this register are 1)To collect data, keep a register and follow up all residents of the Maltese Islands who are diagnosed with cancer, and 2)To provide a surveillance function by using registry data to examine trends by age and gender, by cancer type, over time and across the nation. The first attempts at cancer registration in Malta were started in the mid-1960s. In fact, cancer incidence data from Malta for the time period 1969-1972 were included in the Cancer Incidence in Five Continents, Volume III (IARC, 1976). The present registry started in 1985 and is still ongoing. Initially, only data on cases diagnosed at St. Luke’s Hospital (the major acute general public hospital in Malta at the time) were collected. However, since 1991, the registry has also been collecting data on cases diagnosed in all (public and private) hospitals, clinics and laboratories on the Maltese Islands. Data on cancer site and morphology is coded using the International classification of diseases for oncology (ICD-O) – version 3, revision 2.